Navigation

Breast cancer (metastatic) - fulvestrant

Fulvestrant for the treatment of locally advanced or metastatic breast cancer

Status: History
Expected date of issue: December 2011
Referral date: March 2010
Process: STA
Topic area:
  • Cancer
 

NICE project team

Executive Lead: Andrew Dillon
Technical Lead: Matthew Dyer
Communications manager: Paul Cooney
Project manager: Kate Moore
Top


 

Provisional schedule

Closing date for invited submissions / evidence submission: 1 October 2010
1st appraisal committee meeting: 26 July 2011
2nd appraisal committee meeting 27 September 2011
Top


 

Consultees and commentators

Consultees

 

Commentators (no right to submit or appeal)

 

Manufacturers/sponsors

  • AstraZeneca (fulvestrant)

Patient/carer groups

  • Breakthrough Breast Cancer
  • Breast Cancer Campaign
  • Breast Cancer Care
  • Macmillan Cancer Support

Professional groups

  • Cancer Research UK
  • Royal College of Nursing
  • Royal College of Pathologists
  • Royal College of Physicians

Others

  • Department of Health
  • South Staffordshire NHS PCT
  • Welsh Government

 

 

 

 

General

  • Commissioning Support Appraisals Service
  • Department of Health, Social Services and Public Safety for Northern Ireland
  • Health Improvement Scotland

Comparator manufacturers

  • AstraZeneca (anastrozole)
  • Novartis (letrazole) (CA&U not retuned, not participating)
  • Pfizer (exemestane,)

Relevant research groups

  • None

Evidence review group

  • Liverpool Reviews & Implementation Group, University of Liverpool
  • National Institute for Health Research Health Technology Assessment Programme

Associated guideline groups

  • National Collaborating Centre for Cancer

Associated public health groups

  • None

Top


 

Key documents

This page was last updated: 12 December 2011

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.